LSBio
RELA / NFKB p65 Antibody (aa501-551)

Detection of Human RelA by Western Blot. Samples: Whole cell lysate from 293T (15 and 50 ug), HeLa (50 ug), and Jurkat (50 ug) cells. Antibodies: Affinity purified goat anti-RelA antibody used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 3 minutes.

RELA / NFKB p65 Antibody (aa501-551)

Primary AntibodyLSBio Guarantee
Antibody:Goat Polyclonal
Applications:Immunohistochemistry (general), Immunoprecipitation, Western Blot
Reactivity:Human, Mouse
Format:Liquid
See all Human RELA / NFKB p65 antibodies →
$301.00each
Catalog Number: LS-C290611-10

For bulk orders or custom formulations:

Request a Quote

Overview

Description
NFKB p65 antibody LS-C290611 is an unconjugated goat polyclonal antibody to NFKB p65 (RELA) (aa501-551) from human. It is reactive with human and mouse. Validated for IP and WB. Cited in 1 publication.
Application
IHC, IP, WB
Reactivity
Hu, Ms
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
RELA | NF-kappa-B p65delta3 | NF-kappaB | NFKB3 | p65 | Transcription factor p65 | NF kappaB | NFKB
Recommended Dilution: WB
1:2000 - 1:10000
UniProt Number
Q04206
SwissProt
Q04206

Target

Target
Human RELA / NFKB p65
Antigen Species
Human
Epitope
Region between residue 501 to 551 of human Reticuloendotheliosis Viral Oncogene Homolog A using the numbering given in entry NP_068810.2 (GeneID 5970).
Gene Name
RELA

Antibody

Host Species
Goat
Clonality
Polyclonal
Isotype
IgG

Immunogen

Immunogen
A portion of GeneID: 5970 corresponding to amino acids between 501 and 551 of UniprotID: Q04206
Immunogen Type
Recombinant Protein Fragment

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
Tris-citrate/phosphate buffer, pH 7-8, 0.09% sodium azide.
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at 2-8°C for up to one year.
Recommended Storage Buffer
Tris-citrate
Molecular targeting of renal inflammation using drug delivery technology to inhibit NF-?B improves renal recovery in chronic kidney disease. Alejandro R Chade, Maxx L Williams, Jason E Engel, Erika Williams, Gene L Bidwell rd. American journal of physiology. Renal physiology. 2020 July;319:F139-F148. PubMed: 32538151 PMC: PMC7468833

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.